University of Vermont: Opioid-Related Disorders trials

The registry lists 17 Opioid-Related Disorders studies with University of Vermont as lead sponsor. 1 are open to participants now and 5 have results posted.

Phase 1 2Phase 2 9No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals With OUDRecruitingNCT06288711Not applicable
• Start Treatment and Recovery for Opioid Use DisorderCompletedNCT04505540Not applicableResults posted
• Prolonged Exposure Therapy for PTSD and Opioid Use DisorderCompletedNCT04104022Not applicableResults posted
• Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Use DisorderCompletedNCT04092101Phase 2Results posted
• Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage IICompletedNCT02411357Not applicableResults posted
• Methylnaltrexone for Opioid-induced Constipation in Cancer PatientsCompletedNCT01004393Phase 2Results posted
• Contingency Management to Improve Medication for Opioid Use Disorder Continuation After the Emergency DepartmentCompletedNCT07129902Not applicable
• Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate DecisionsCompletedNCT04049799
• Interim Buprenorphine Treatment to Bridge Waitlist Delays: Stage II EvaluationStatus unknownNCT03420313Phase 2
• Improving Effective Contraceptive Use Among Opioid-maintained WomenCompletedNCT01425060Phase 1
• Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22CompletedNCT00000240Phase 2
• Alternate Day Buprenorphine Administration, Phase XI - 16CompletedNCT00000234Phase 2
• Alternate Day Buprenorphine Administration, Phase IX - 14CompletedNCT00000232Phase 2
• Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12CompletedNCT00000230Phase 2
• Buprenorphine Detox With Two Types of Treatment. BBD II - 11CompletedNCT00000229Phase 2
• Alternate-Day Buprenorphine Administration. Phase VIII - 9CompletedNCT00000227Phase 2
• Buprenorphine Dose Alteration Study - 1CompletedNCT00000219Phase 1